EBIT: Income before interest and taxes.
Sionna Therapeutics, Inc. (SION) had EBIT of $-19.66M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-16.48M |
|
-- |
|
-- |
|
$19.66M |
|
$-19.66M |
|
$3.18M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
$-16.48M |
|
|
EBIT |
$-19.66M |
$-20.20M |
|
26.60M |
|
26.60M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$273.68M |
|
$2.39M |
|
$95.99M |
|
$369.67M |
|
$9.53M |
|
-- |
|
$8.38M |
|
$17.91M |
|
$351.77M |
|
$351.77M |
|
$351.77M |
|
44.09M |
|
| Cash Flow Statement Financials | |
$-16.29M |
|
$-141.19M |
|
$202.39M |
|
$38.75M |
|
$83.66M |
|
$44.91M |
|
$2.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.69% |
|
-4.69% |
|
-4.46% |
|
-4.69% |
|
$7.98 |
|
$-0.62 |
|
$-0.61 |
|